EUVIMEDEUVIMED entdecken
Crossref

Synthesis, Labeling, and Biological Evaluation of P2Y 12 Receptor Radioligands for Positron Emission Tomography Imaging of Neuroinflammation

Eugénie Pincemail, Marie-Anne Peyronneau iD, Caroline Denis, Hayet Bensalah, Margot Corbel iD, Sébastien Goutal, Maud Goislard, Haneen Al Hroub iD, Marie Théry, Sébastien Beuché, Hashem Ali M Al Musawi iD, Fabien Chauveau iD und 6 weitere

ACS Chemical Neuroscience · 2025

DOI: 10.1021/acschemneuro.5c00187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Eugénie Pincemail und 17 weiteren Autor:innen. Beteiligte Einrichtung: Paris-Saclay University, CEA, CNRS, Inserm, BioMaps, SHFJ, 91401 Orsay, France. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Radiopharmaceuticals, Receptors, Purinergic P2Y12, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, Deutsche Forschungsgemeinschaft, Centre National de la Recherche Scientifique.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The P2Y12 receptor (P2Y12R) is a G-protein-coupled receptor whose expression level is directly correlated to microglial activation. Herein, we report on the design of a series of new P2Y12R ligands and the radiolabeling and characterization of two positron emission tomography (PET) tracers, [11C]37 and [18F]41. These compounds were evaluated by autoradiography studies on rat brain slices exhibiting overexpression of human P2Y12Rs (AAV-hP2Y12R). Metabolism and biodistribution of [18F]41 were evaluated ex vivo in healthy rats and indicated good metabolic stability with 41% of unchanged radioligand 1 h post injection and a limited crossing of the blood-brain barrier with a brain uptake of 0.02%ID/g 1 h post injection. In vivo PET imaging performed in the AAV-hP2Y12R rat model confirmed this low brain uptake, and no significant difference was found in the transfected (SUVmean 0.14 ± 0.01) versus contralateral (SUVmean 0.13 ± 0.01) striatum of the AAV-hP2Y12R model. Similar results were observed in healthy rats and in nonhuman primates. Additional studies in the presence of tariquidar led to a 3-4-fold increase in the [18F]41 brain concentration, suggesting that [18F]41 is a P-glycoprotein substrate. Future work will focus on improving radioligand design to enhance blood-brain barrier permeation and to reduce efflux transport.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyRadiopharmaceuticalsReceptors, Purinergic P2Y12BrainNeuroinflammatory DiseasesAnimalsRatsHumansMaleTissue DistributionBlood-Brain BarrierFluorine RadioisotopesLigandsRats, Sprague-DawleyCarbon RadioisotopesAutoradiography

Stichwörter der Autor:innen

P2Y12RPET ligandscarbon-11fluorine-18microglial stateneuroinflammation

Substanzen

RadiopharmaceuticalsReceptors, Purinergic P2Y12Fluorine RadioisotopesLigandsCarbon Radioisotopes

Autor:innen und Institutionen

  • Paris-Saclay University, CEA, CNRS, Inserm, BioMaps, SHFJ, 91401 Orsay, France.
  • Paris-Saclay University, CEA, CNRS, MIRCen, Laboratoire des Maladies Neurodegeneratives, 92265 Fontenay-aux-Roses, France.
  • PharmaCenter Bonn, Pharmaceutical Institute, Department of Pharmaceutical & Medicinal Chemistry, University of Bonn, 53121 Bonn, Germany.
  • Université Claude Bernard Lyon 1, Centre de Recherche en Neurosciences de Lyon, Inserm U1028, CNRS UMR5292, BIORAN, Groupement Hospitalier Est, 69677 Bron, France.

ORCID-Profile: Marie-Anne Peyronneau, Margot Corbel, Haneen Al Hroub, Hashem Ali M Al Musawi, Fabien Chauveau, Alexis-Pierre Bemelmans, Christa E Müller, Bertrand Kuhnast, Alexandra Winkeler, Mylène Richard

Förderung

  • Agence Nationale de la Recherche
  • Deutsche Forschungsgemeinschaft
  • Centre National de la Recherche Scientifique
  • Commissariat à l'Énergie Atomique et aux Énergies Alternatives

Zitieren

APA

Pincemail, E., Peyronneau, M. A., Denis, C., Bensalah, H., Corbel, M., Goutal, S., Goislard, M., Al Hroub, H., Théry, M., Beuché, S., Al Musawi, H. A. M., Chauveau, F., Van Camp, N., Bemelmans, A. P., Müller, C. E., Kuhnast, B., Winkeler, A., & Richard, M. (2025). Synthesis, Labeling, and Biological Evaluation of P2Y 12 Receptor Radioligands for Positron Emission Tomography Imaging of Neuroinflammation. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00187

Vancouver

Pincemail E, Peyronneau MA, Denis C, Bensalah H, Corbel M, Goutal S, et al. Synthesis, Labeling, and Biological Evaluation of P2Y 12 Receptor Radioligands for Positron Emission Tomography Imaging of Neuroinflammation. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00187

BibTeX
@article{Pincemail2025,
  author = {Pincemail, Eugénie and Peyronneau, Marie-Anne and Denis, Caroline and Bensalah, Hayet and Corbel, Margot and Goutal, Sébastien and Goislard, Maud and Al Hroub, Haneen and Théry, Marie and Beuché, Sébastien and Al Musawi, Hashem Ali M and Chauveau, Fabien and Van Camp, Nadja and Bemelmans, Alexis-Pierre and Müller, Christa E and Kuhnast, Bertrand and Winkeler, Alexandra and Richard, Mylène},
  title = {Synthesis, Labeling, and Biological Evaluation of P2Y 12 Receptor Radioligands for Positron Emission Tomography Imaging of Neuroinflammation},
  journal = {ACS Chemical Neuroscience},
  year = {2025},
  doi = {10.1021/acschemneuro.5c00187}
}
Kostenlos starten →